AstraZeneca 's experimental drug baxdrostat has been successful in lowering high blood pressure in a late-stage study of people whose condition was hard to control or treat, the Anglo-Swedish drugmaker said on Monday, sending shares up 2%.

Kinder Morgan offers stable, fee-based revenues with 90% decoupled from commodity prices, making it a reliable cash flow generator. Strategic investments in renewable natural gas and hydrogen, plus a robust project backlog, position Kinder Morgan for steady, not explosive growth. In this earnings preview, I want to highlight some possible tailwinds that will benefit Kinder Morgan, one of which could be the result of the US-EU trade talks.

Billionaire Elon Musk said in a Monday post on X he does not support a merger between Tesla and his artificial intelligence startup xAI.

Trump's Russia sanctions may disrupt crude oil flows, driving bullish oil outlook and higher futures amid supply risk and freight bottlenecks.

Since the mid-1960s, Berkshire Hathaway's (BRK.A -0.62%) (BRK.B -0.52%) Warren Buffett has been consistently outpacing the benchmark S&P 500 in the return department. As of the closing bell on July 10, the Oracle of Omaha has overseen a cumulative return in his company's Class A shares (BRK.A) of 5,873,451% since becoming CEO.

Coca-Cola (KO 0.20%) is performing very strongly today, with organic sales up 6% in the first quarter of 2025. That comes amid a tough backdrop for consumer staples companies, thanks to inflation and consumers' worries about their finances.

Gold holds near $3,355 as rising tariffs and geopolitical risk boost safe-haven appeal. Silver outperforms, gaining 3.5% amid inflation hedging.

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that all primary and secondary endpoints were met in two Phase 3 randomized, double-blind, placebo-controlled studies of oveporexton (TAK-861), a potential first-in-class investigational oral orexin receptor 2 (OX2R)-selective agonist, in narcolepsy type 1 (NT1). NT1 is caused by the loss of orexin-producing neurons in the brain. Orexin agonists are designed to address this underlying orexin deficiency.

Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) has delivered a solid operational update from the Segilola mine in Nigeria for the second quarter, alongside a progress report on its assets in Senegal and Côte d'Ivoire. Between April and June, the company poured just under 23,000 ounces of gold.

iShares MSCI Turkey ETF offers diversified exposure to Turkey's high-growth sectors—industrials, financials, and consumer defensives—positioning it for potential upside amid economic reforms. Risks like currency depreciation, high inflation, and political instability remain significant and could undermine returns for USD-based investors. TUR's lower expense ratio and broader diversification make it more appealing than ITKY, but concentrated holdings and low liquidity add to the risk.

South Korea's transport ministry is preparing to order all airlines in the country that operate Boeing jets to examine fuel switches in accordance with a 2018 advisory from the U.S. Federal Aviation Administration, the ministry's foreign media spokesperson said on Monday.

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the age of 50 at a higher risk of the disease.

Oil steadies as IEA warns of surplus, but Saudi exports and summer demand fuel bullish sentiment amid rising geopolitical risks.

If there's a beaten-down “non-correlated” (or uncorrelated) asset class to the S&P 500's bull market, it's the Russell 2000 Value segment, and the biggest concentration within that asset class is financials. Citigroup reports on July 15th before the opening bell, and analyst consensus coming into the Q2 earnings release is expecting $1.60 in EPS on $20.98 billion in revenue, for expected year-over-year growth of 5% and 4% respectively. JPM trades at 15x-16x earnings for expected high-single digit EPS growth over the next 3 years, while it likely can still generate high-teens, low-20% ROTCE or ROE.

Tel-Aviv, Israel, July 14, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today announced that it received and accepted, following the approval of its Board of Directors, commitments from several Israeli institutional and classified investors to buy 926,000 ordinary shares of the Company in a private placement (the “Private Placement”). As a result of the Private Placement, an affiliate of Menora Mivtachim Holdings Ltd. (one of Israel's largest institutional investors), which holds securities for …

Ventas' recent dividend increase and international exposure position it well for future growth, despite its current yield lagging behind Treasuries. Lower interest rates and management's strong execution could make VTR's dividend more attractive and support further upside. Technical analysis shows bullish price action, improving momentum, institutional support, and rising relative strength vs. the S&P 500.

HAMPSHIRE, United Kingdom, July 14, 2025 (GLOBE NEWSWIRE) -- A new study from Juniper Research, the foremost experts in fintech and payment markets, has identified the leaders in subscription management platforms globally for 2025. The Leaderboard evaluated 20 key subscription economy players against a robust set of criteria, including the size of their operations, commercial proposition and the comprehensiveness of their billing service.

China's market regulator has granted a conditional approval for software firm Synopsys to acquire Ansys , according to a statement released by the regulator on Monday.

Bank of Montreal remains my top Canadian bank pick, delivering 42% returns since 2023, thanks to its superior risk-reward profile and successful growth strategy. National Bank of Canada has emerged as another core Canadian bank holding, with disciplined expansion, strong capital, and standout revenue growth, especially after acquiring Canadian Western Bank. Royal Bank and CIBC are on my investment radar for future opportunities, while TD and Scotiabank face strategic and regulatory headwinds limiting near-term upside.

HTUS employs a tactical, model-driven approach to S&P 500 exposure, combining market timing and options income strategies. In 2024, the fund delivered a very high yield that is not typical of the strategy based on historical data. HTUS has underperformed the benchmark since its inception and is on par with it since 2023, with a deeper drawdown.